Raj, Ranjan, Aditya Kumar, Prachi Sood, Roshan Kumar, and Vinod Rana. “Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel As First Line Treatment in Women With Advanced Breast Cancer”. Journal for Research in Applied Sciences and Biotechnology 2, no. 3 (June 12, 2023): 55–63. Accessed July 7, 2024. https://jrasb.stallionpublication.com/index.php/jrasb/article/view/232.